We are proud to announce that Santero therapeutics will be a speaker at the AMR Conference in Basel on February 25 and 26!
On February 26 at 3.30pm, Cédric Govaerts co-founder of Santero therapeutics, will present the results of a major scientific discovery, the fruit of almost 20 years of research. This breakthrough paves the way for a Phase 1 clinical trial, marking a key step in the development of a new generation of antibiotics.
In recent months, our teams have identified several promising molecules (hit-to-lead phase) and, in recent weeks, have twice demonstrated the in vivo efficacy of two of them. These results reinforce our commitment to combating antimicrobial resistance, one of the major challenges facing public health.
Will you be in Basel? Come and chat with us!
https://amr-conference.com/program